Monitoring Agency Report

August 14, 2026 BSE Limited National Stock Exchange of India Ltd Phiroze Jeejeebhoy Tower, Exchange Plaza, 5th Floor, Plot C/1, G Block, Dalal Street, Bandra - Kurla Complex, Bandra (E), Mumbai - 400 001. Mumbai - 400 051. BSE Scrip Code: 544743 NSE Symbol: AEROPLANE Dear Sir(s) / Madam(s), Sub: Submission of Monitoring Agency Report for the quarter ended June 30, 2026 Pursuant to the regulations 32(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and regulation 41(4) of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, please find enclosed the Monitoring Agency Report for the quarter ended June 30, 2026, issued by Care Ratings Limited, Monitoring Agency, appointed to monitor the utilization of proceeds of the public issue of the Company. The aforesaid information will be made available on the Company's website at www.aeroplanerice.com This is for your information, record and necessary dissemination to all the stakeholders. Thanking you, Yours faithfully, For Amir Chand Jagdish Kumar (Exports) Limited Sadhna Khurana Company Secretary and Compliance Officer Mem. No. A24534 No. CARE/NRO/GEN/2026-27/1112 The Board of Directors Amir Chand Jagdish Kumar (Exports) Limited Ground Floor, 2735/9, Mohan Lal Palace, Naya Bazar, Chandni Chowk Area Delhi, New Delhi, India - 110006 August 14, 2026 Dear Sir, Monitoring Agency Report for the quarter ended June 30, 2026 - in relation to the IPO of Amir Chand Jagdish Kumar (Exports) Limited (“the Company”) We write in our capacity of Monitoring Agency for the Initial Public Offer (IPO) for the amount aggregating to Rs. 440.00 crore of the Company and refer to our duties cast under Regulation 41 of the Securities & Exchange Board of India (Issue of Capital & Disclosure Requirements) Regulations. In this connection, we are enclosing the Monitoring Agency Report for the quarter ended June 30, 2026, as per aforesaid SEBI Regulations and Monitoring Agency Agreement dated January 29, 2026. Request you to kindly take the same on records. Thanking you, Yours faithfully, Rajan Sukhija Associate Director Rajan.Sukhija@careedge.in CARE Ratings Limited 9th floor, C-001/A2, Berger Towers, Sector 16B, 4th Floor, Godrej Coliseum, Somaiya Hospital Noida, Road, Off Eastern Express Highway, Sion (East), Gautam Budh Nagar, Uttar Pradesh -201301 Mumbai - 400 022 Phone: +91-120-4452000 Phone: +91-22-6754 3456 Email: care@careedge.in • www.careedge.in CIN-L67190MH1993PLC071691 Report of the Monitoring Agency Name of the issuer: Amir Chand Jagdish Kumar (Exports) Limited For quarter ended: June 30, 2026 Name of the Monitoring Agency: CARE Ratings Limited (a) Deviation from the objects: Nil (b) Range of Deviation: Not applicable Declaration: We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The MA does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA and any issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an expert as defined under Section 2(38) of the Companies Act, 2013. The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains and may receive separate compensation for its ratings and certain credit-related analyses. We confirm that there is no conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds by the issuer, or while undertaking credit rating or other commercial transactions with the entity. We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments, where applicable. There are certain sections of the report under the title “Comments of the Board of Directors”, that shall be captured by the Issuer’s Management / Audit Committee of the Board of Directors subsequent to the MA submitting their report to the issuer and before dissemination of the report through stock exchanges. These sections have not been reviewed by the MA, and the MA takes no responsibility for such comments of the issuer’s Management/Board. Signature: Name and designation of the Authorized Signatory: Rajan Sukhija Designation of Authorized person/Signing Authority: Associate Director CARE Ratings Limited 9th floor, C-001/A2, Berger Towers, Sector 16B, 4th Floor, Godrej Coliseum, Somaiya Hospital Noida, Road, Off Eastern Express Highway, Sion (East), Gautam Budh Nagar, Uttar Pradesh -201301 Mumbai - 400 022 Phone: +91-120-4452000 Phone: +91-22-6754 3456 Email: care@careedge.in • www.careedge.in CIN-L67190MH1993PLC071691 1) Issuer Details: Name of the issuer : Amir Chand Jagdish Kumar (Exports) Limited Name of the promoter : Jagdish Kumar Suri, Rahul Suri, Ramnika Suri Industry/sector to which it belongs : Other Agricultural Products 2) Issue Details Issue Period : March 24, 2026, to March 27, 2026 Type of issue (public/rights) : Initial Public Offer Type of specified securities : Equity Shares IPO Grading, if any : Not applicable Issue size (in crore) : Rs. 440.00 crore 3) Details of the arrangement made to ensure the monitoring of issue proceeds: Source of information / certifications considered Comments of the Comments of the Particulars Reply by Monitoring Agency for Monitoring Agency Board of Directors preparation of report Bank statement, CA The IPO proceeds have been utilized Whether all utilization is as per the disclosures Yes Certificate* and Management towards the objectives mentioned in the No comments in the Offer Document? Certificate offer document. Whether shareholder approval has been Bank statement, CA No material obtained in case of material deviations# from certificate* and Management Not applicable No comments deviation expenditures disclosed in the Offer Document? certificate A substantial portion amounting to Rs. The said proceeds were utilized in 398.18 crore out of the total allocation of Q1FY27 strictly towards the object Whether the means of finance for the CA certificate* and No Rs. 400.00 crore was utilized towards specified in the Offer Document, i.e., disclosed objects of the issue have changed? Management certificate working capital requirements during working capital requirements. The Q1FY27. Accordingly, while the proceeds accelerated utilization was driven by CARE Ratings Limited 9th floor, C-001/A2, Berger Towers, Sector 16B, 4th Floor, Godrej Coliseum, Somaiya Hospital Noida, Road, Off Eastern Express Highway, Sion (East), Gautam Budh Nagar, Uttar Pradesh -201301 Mumbai - 400 022 Phone: +91-120-4452000 Phone: +91-22-6754 3456 Email: care@careedge.in • www.careedge.in CIN-L67190MH1993PLC071691 Source of information / certifications considered Comments of the Comments of the Particulars Reply by Monitoring Agency for Monitoring Agency Board of Directors preparation of report have been deployed towards the stated operational requirements to support object of the Issue, this accelerated ongoing revenue growth and business utilization may have implications for the expansion during the quarter. Also, due company's future working capital to less utilization of bank credit limit requirements and funding position. company saved on interest cost. Is there any ma [Showing first 8,000 characters — download PDF for full document]